DeepMind’s New AI Can Predict Genetic Diseases – WIRED

DeepMind, the artificial intelligence (AI) company owned by Alphabet, has made a groundbreaking development in the field of genetics. Their latest AI model has the ability to predict genetic diseases with remarkable accuracy. This breakthrough has the potential to revolutionize the way genetic disorders are diagnosed and treated.

The AI model, called AlphaFold, utilizes deep learning algorithms to analyze genetic data and predict the three-dimensional structure of proteins. Proteins play a crucial role in the functioning of cells and are often associated with various genetic diseases. Understanding their structure is vital for identifying potential disease-causing mutations.

Traditionally, determining the structure of proteins has been a time-consuming and expensive process. Scientists have relied on experimental methods such as X-ray crystallography or cryo-electron microscopy. However, these methods are not always feasible for every protein, leaving many structures unknown.

AlphaFold, on the other hand, uses a different approach. It has been trained on a vast amount of genetic and protein data, allowing it to

Source (

Leave a comment

Your email address will not be published. Required fields are marked *